Breaking News Instant updates and real-time market news.

2020-03-17 09:47:17 09:47 03/17/20 03/17 09:47 03/17/20 09:47	CM Financial Inc (Notes) [6.125% Notes Due 2023] trading halted, volatility trading pause

TODAY'S FREE FLY STORIES

Upgrade	Tellurian upgraded to Outperform with $5 target at Wolfe Research » 07:14 01/21/21 01/21 07:14 01/21/21 07:14 TELL Tellurian $2.48 / -0.105 (-4.06%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Tellurian surges as Petronet reportedly renews investment agreement TELL Tellurian $2.48 / -0.105 (-4.06%) 01/20/21 Wolfe Research Tellurian upgraded to Outperform from Peer Perform at Wolfe Research 06/10/20 Fly Intel: Top five analyst initiations 06/10/20 Roth Capital Tellurian initiated with a Buy at Roth Capital 06/01/20 Stifel Tellurian downgraded to Sell from Hold at Stifel TELL Tellurian $2.48 / -0.105 (-4.06%) 08/05/20 Tellurian reports Q2 EPS (53c), consensus (11c) TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Petronet renews deal over $2.5B investment in Tellurian project, Reuters says TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Fly Intel: Wall Street's top stories for Tuesday 03/01/21 26th Annual Energy Virtual Summit TELL Tellurian $2.48 / -0.105 (-4.06%) 11/05/20 Tellurian options imply 41.6% move in share price post-earnings 11/05/20 Largest borrow rate increases among liquid names 11/03/20 Largest borrow rate increases among liquid names 10/27/20 Largest borrow rate increases among liquid names
Hot Stocks	Genetic Technologies provides update on COVID-19 disease severity risk test » 07:14 01/21/21 01/21 07:14 01/21/21 07:14 GENE Genetic Technologies $4.32 / -0.03 (-0.69%) Genetic Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Options GENE Genetic Technologies $4.32 / -0.03 (-0.69%) 12/02/20 Genetic Technologies secures U.S., Australia distribution rights for Predictix 10/01/20 Genetic Technologies outlines findings in relation to COVID-19 Risk Test 09/15/20 Genetic Technologies offers update on COVID-19 disease severity test development 09/11/20 Genetic Technologies commences U.S. sales via online health platform GENE Genetic Technologies $4.32 / -0.03 (-0.69%) 01/05/21 Largest borrow rate increases among liquid names 12/23/20 Largest borrow rate increases among liquid names 07/29/20 Thirteen new option listings on July 29th
Recommendations	Expedia price target raised to $164 from $145 at Truist » 07:12 01/21/21 01/21 07:12 01/21/21 07:12 EXPE Expedia $141.75 / -0.99 (-0.69%) Truist analyst Naved Khan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EXPE Expedia $141.75 / -0.99 (-0.69%) 12/08/20 Porch.com appoints Matthew Cullen as general counsel, secretary 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter 11/04/20 Expedia: July was down in lodgings and gross bookings 11/04/20 Expedia reports Q3 room night growth down 58% EXPE Expedia $141.75 / -0.99 (-0.69%) 01/15/21 BTIG Expedia price target raised to $175 from $145 at BTIG 01/15/21 JMP Securities Expedia price target raised to $165 from $115 at JMP Securities 01/08/21 Mizuho Expedia price target raised to $115 from $95 at Mizuho 01/04/21 Deutsche Bank Expedia price target raised to $148 from $108 at Deutsche Bank EXPE Expedia $141.75 / -0.99 (-0.69%) 11/04/20 Expedia reports Q3 adjusted EPS (22c), consensus (79c) 11/04/20 Notable companies reporting after market close 07/30/20 Expedia reports Q2 EPS ($4.09), consensus ($3.34) 07/30/20 Expedia reports Q2 adjusted EPS ($4.09), consensus ($3.34) EXPE Expedia $141.75 / -0.99 (-0.69%) 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports 07/30/20 Affirm preparing IPO for up to $10B, WSJ reports EXPE Expedia $141.75 / -0.99 (-0.69%) 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 12/14/20 Disney, Airbnb downgrades among today's top calls on Wall Street 12/10/20 Tesla downgrade, Disney initiation among today's top calls on Wall Street 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street EXPE Expedia $141.75 / -0.99 (-0.69%) 12/16/20 Expedia call volume above normal and directionally bullish 12/10/20 Expedia call volume above normal and directionally bullish 11/20/20 Expedia call volume above normal and directionally bullish 11/05/20 Early notable gainers among liquid option names on November 5th
Recommendations	Apple price target raised to $152 from $144 at Morgan Stanley » 07:12 01/21/21 01/21 07:12 01/21/21 07:12 AAPL Apple $131.98 / +4.13 (+3.23%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $131.98 / +4.13 (+3.23%) 01/19/21 Netflix says past year 'testament' to company's approach 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 VirnetX says court affirms jury award of $502.8M against Apple 01/15/21 VirnetX jumps after court denies Apple motion for new patent trial AAPL Apple $131.98 / +4.13 (+3.23%) 01/19/21 Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/19/21 BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital 01/15/21 Goldman Sachs Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating 01/15/21 Loop Capital Apple price target raised to $155 from $131 at Loop Capital AAPL Apple $131.98 / +4.13 (+3.23%) 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 10/29/20 Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year 10/29/20 Apple reports Q4 EPS 73c, consensus 70c AAPL Apple $131.98 / +4.13 (+3.23%) 06:34 Today Apple's first headset to focus on virtual reality, Bloomberg reports 01/17/21 Apple considering foldable iPhone, minor changes for 2021 models, Bloomberg says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/15/21 Apple to re-close stores in Texas, North Carolina, Georgia, Bloomberg says AAPL Apple $131.98 / +4.13 (+3.23%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/20/21 Street Fight: Analysts diverge on Lumentum after Coherent deal announcement 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/27/21 Apple - AAPL 02/23/21 Apple, Inc. AAPL Apple $131.98 / +4.13 (+3.23%) 01/20/21 Notable open interest changes for January 20th 01/19/21 Notable open interest changes for January 19th 01/15/21 Notable open interest changes for January 15th 01/14/21 Notable open interest changes for January 14th
Hot Stocks	Fifth Third expects to repurchase up to $180M in Q1 » 07:11 01/21/21 01/21 07:11 01/21/21 07:11 FITB Fifth Third $31.32 / -0.75 (-2.34%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:39 Today Fifth Third CEO says capital, liquidity levels 'further improved' in Q4 06:32 Today Fifth Third reports Q4 net interest margin 2.58% vs. 3.27% a year ago 01/04/21 Fifth Third completes acquisition of Hammond Hanlon Camp 12/07/20 Fifth Third Bank announces $2.8B investment to accelerate racial equity FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/07/21 Goldman Sachs Fifth Third upgraded to Buy from Neutral at Goldman Sachs 01/06/21 Deutsche Bank Fifth Third price target raised to $30 from $24 at Deutsche Bank 01/04/21 Barclays Fifth Third price target raised to $37 from $28 at Barclays 12/07/20 Evercore ISI Fifth Third upgraded to In Line from Underperform at Evercore ISI FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:31 Today Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says FITB Fifth Third $31.32 / -0.75 (-2.34%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 09:00 Today Fifth Third - FITB

Hot Stocks	Climb Channel Solutions launches Climb Elevate » 07:11 01/21/21 01/21 07:11 01/21/21 07:11 WSTG Wayside Technology $19.57 / +0.11 (+0.57%) Climb Channel Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News WSTG Wayside Technology $19.57 / +0.11 (+0.57%) 01/19/21 Climb Channel Solutions partners with ChannelOnline 01/12/21 TechXtend, Resiliency Technologies announce national partnership 12/14/20 Climb Channel Solutions appoints Charles Bass as CMO 12/03/20 Climb Channel Solutions to distribute SUSE's open source solutions
Recommendations	Cinedigm price target raised to $3 from $2 at Alliance Global Partners » 07:10 01/21/21 01/21 07:10 01/21/21 07:10 CIDM Cinedigm $1.21 / +0.12 (+11.01%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CIDM Cinedigm $1.21 / +0.12 (+11.01%) 01/19/21 Cinedigm acquires Fandor, terms not disclosed 12/08/20 Cinedigm, Spherex partner on global content localization, compliance 11/30/20 Cinedigm acquires over 1,000 hours of premium film, TV programming 11/19/20 Cinedigm launching Whistle TV streaming channel on Roku Channel CIDM Cinedigm $1.21 / +0.12 (+11.01%) 10/16/20 Alliance Global Partners Cinedigm initiated with a Buy at Alliance Global Partners 07/07/20 Benchmark Cinedigm initiated with a Speculative Buy at Benchmark 07/07/20 Benchmark Cinedigm initiated with a Speculative Buy at Benchmark
Recommendations	Booking Holdings price target raised to $2480 from $2120 at Truist » 07:10 01/21/21 01/21 07:10 01/21/21 07:10 BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) Truist analyst Naved Khan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 11/16/20 Lone Pine buys Square, exits Visa in Q3 10/14/20 Eightfold.ai to modernize Booking.com's global talent acquisition processes 09/10/20 Booking Holdings to reduce Booking.com's global workforce by about 10% 08/17/20 Soros boosts stakes in Alphabet, T-Mobile, takes position in Alibaba BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/08/21 Mizuho Booking Holdings price target raised to $2,345 from $2,020 at Mizuho 01/04/21 Fly Intel: Top five analyst initiations 01/04/21 Loop Capital Booking Holdings initiated with a Hold at Loop Capital 01/04/21 Deutsche Bank Booking Holdings price target raised to $2,585 from $1,985 at Deutsche Bank BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 11/05/20 Booking CEO says COVID-19 surge to impact travel in near-term 11/05/20 Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13 11/05/20 Notable companies reporting after market close 08/06/20 Booking Holdings reports Q2 adjusted EPS ($10.81), consensus ($11.70) BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 12/14/20 Disney, Airbnb downgrades among today's top calls on Wall Street 12/10/20 Tesla downgrade, Disney initiation among today's top calls on Wall Street 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/04/21 Booking Holdings put volume heavy and directionally bearish 09/03/20 Booking Holdings put volume heavy and directionally bearish
Hot Stocks	Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board » 07:09 01/21/21 01/21 07:09 01/21/21 07:09 CERE Cerevel Therapeutics $14.36 / -0.13 (-0.90%) , PFE Pfizer $36.48 / -0.26 (-0.71%) Cerevel Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CERE PFE CERE Cerevel Therapeutics $14.36 / -0.13 (-0.90%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 01/19/21 Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer 12/08/20 Cerevel Therapeutics appoints Ruth McKernan to board of directors 10/30/20 Cerevel Therapeutics doses first patients in Phase 3 trials of tavapadon PFE Pfizer $36.48 / -0.26 (-0.71%) 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/13/21 Siga Technologies: Meridian Medical to purchase up to $33M of oral TPOXX CERE PFE CERE Cerevel Therapeutics $14.36 / -0.13 (-0.90%) 12/10/20 Goldman Sachs Cerevel Therapeutics initiated with a Buy at Goldman Sachs 11/23/20 Jefferies Cerevel Therapeutics initiated with a Buy at Jefferies 11/09/20 Fly Intel: Top five analyst initiations 11/09/20 Stifel Cerevel Therapeutics initiated with a Buy at Stifel PFE Pfizer $36.48 / -0.26 (-0.71%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg PFE PFE Pfizer $36.48 / -0.26 (-0.71%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 PFE PFE Pfizer $36.48 / -0.26 (-0.71%) 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/18/21 NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports CERE PFE CERE Cerevel Therapeutics $14.36 / -0.13 (-0.90%) 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades PFE Pfizer $36.48 / -0.26 (-0.71%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE PFE Pfizer $36.48 / -0.26 (-0.71%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th
Initiation	SolarEdge initiated with an Overweight at Morgan Stanley » 07:09 01/21/21 01/21 07:09 01/21/21 07:09 SEDG SolarEdge $297.20 / +2.11 (+0.72%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SEDG SolarEdge $297.20 / +2.11 (+0.72%) 12/23/20 SolarEdge appoints Yogev Barak as Chief Marketing Officer 11/02/20 SolarEdge falls 12% to $234.44 after below-consensus Q3 revenue, Q4 guidance 09/01/20 SolarEdge reports Avida resigns from board of directors 08/03/20 SolarEdge up 11.5% at $193.50 per share after Q2 earnings beat and guidance SEDG SolarEdge $297.20 / +2.11 (+0.72%) 01/20/21 JPMorgan SolarEdge price target raised to $387 from $371 at JPMorgan 01/20/21 Credit Suisse SolarEdge price target raised to $284 from $235 at Credit Suisse 01/19/21 Goldman Sachs Buy the dip on Enphase Energy after Tesla inverter news, says Goldman Sachs 01/19/21 Piper Sandler SolarEdge price target raised to $340 from $325 at Piper Sandler SEDG SolarEdge $297.20 / +2.11 (+0.72%) 11/02/20 SolarEdge sees Q4 revenue $345M-$365M, consensus $389.57M 11/02/20 SolarEdge reports Q3 EPS $1.21, consensus 82c 08/03/20 SolarEdge sees Q3 revenue $325M-$350M, consensus $330.76M 08/03/20 SolarEdge reports Q2 EPS 97c, consensus 69c SEDG SolarEdge $297.20 / +2.11 (+0.72%) 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 11:00 Today Energy - Residential Solar

Hot Stocks	Travelers reports Q4 consolidated combined ratio of 86.7% » 07:09 01/21/21 01/21 07:09 01/21/21 07:09 TRV Travelers $145.04 / +1.5 (+1.05%) In Q4: Consolidated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TRV Travelers $145.04 / +1.5 (+1.05%) 06:58 Today Travelers reports book value per share of $115.68, up 14% from year-end 2019 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed TRV Travelers $145.04 / +1.5 (+1.05%) 06:57 Today Travelers reports Q4 core EPS $4.91, consensus $3.18 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TRV Travelers $145.04 / +1.5 (+1.05%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today Travelers - TRV
Hot Stocks	KeyCorp sees long-term ROTCE 16%-19%, cash efficiency ratio 54%-56% » 07:09 01/21/21 01/21 07:09 01/21/21 07:09 KEY KeyCorp $18.29 / -0.26 (-1.40%) Sees positive operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KEY KeyCorp $18.29 / -0.26 (-1.40%) 07:08 Today KeyCorp sees FY21 NII relatively stable, including ongoing PPP participation 06:36 Today KeyCorp announces up to $900M share repurchase program 12/03/20 Accenture names former KeyCorp CEO Mooney to board 10/21/20 KeyCorp expects to be back on path to achieving LT targets KEY KeyCorp $18.29 / -0.26 (-1.40%) 01/06/21 Deutsche Bank KeyCorp price target raised to $18 from $14 at Deutsche Bank 01/04/21 Barclays KeyCorp price target raised to $20 from $15 at Barclays 10/26/20 Fly Intel: Top five analyst downgrades 10/26/20 Wedbush KeyCorp downgraded to Neutral on valuation, headwinds at Wedbush KEY KeyCorp $18.29 / -0.26 (-1.40%) 06:34 Today KeyCorp reports Q4 EPS 56c, consensus 43c 10/21/20 KeyCorp reports Q3 EPS 41c, consensus 37c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open KEY KeyCorp $18.29 / -0.26 (-1.40%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says KEY KeyCorp $18.29 / -0.26 (-1.40%) 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street 07/22/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 10:00 Today KeyCorp - KEY KEY KeyCorp $18.29 / -0.26 (-1.40%) 08/11/20 KeyCorp call volume above normal and directionally bullish
Hot Stocks	KeyCorp sees FY21 NII relatively stable, including ongoing PPP participation » 07:08 01/21/21 01/21 07:08 01/21/21 07:08 KEY KeyCorp $18.29 / -0.26 (-1.40%) Sees FY21 noninterest… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KEY KeyCorp $18.29 / -0.26 (-1.40%) 06:36 Today KeyCorp announces up to $900M share repurchase program 12/03/20 Accenture names former KeyCorp CEO Mooney to board 10/21/20 KeyCorp expects to be back on path to achieving LT targets 10/21/20 KeyCorp has decided to discontinue originating indirect auto loans KEY KeyCorp $18.29 / -0.26 (-1.40%) 01/06/21 Deutsche Bank KeyCorp price target raised to $18 from $14 at Deutsche Bank 01/04/21 Barclays KeyCorp price target raised to $20 from $15 at Barclays 10/26/20 Fly Intel: Top five analyst downgrades 10/26/20 Wedbush KeyCorp downgraded to Neutral on valuation, headwinds at Wedbush KEY KeyCorp $18.29 / -0.26 (-1.40%) 06:34 Today KeyCorp reports Q4 EPS 56c, consensus 43c 10/21/20 KeyCorp reports Q3 EPS 41c, consensus 37c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open KEY KeyCorp $18.29 / -0.26 (-1.40%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says KEY KeyCorp $18.29 / -0.26 (-1.40%) 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street 07/22/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 10:00 Today KeyCorp - KEY KEY KeyCorp $18.29 / -0.26 (-1.40%) 08/11/20 KeyCorp call volume above normal and directionally bullish
Hot Stocks	Microbot Medical announces additions to Scientific Advisory Board » 07:08 01/21/21 01/21 07:08 01/21/21 07:08 MBOT Microbot Medical $8.21 / +0.13 (+1.61%) Microbot Medical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly MBOT Microbot Medical $8.21 / +0.13 (+1.61%) 01/14/21 Microbot announces results of additional animal feasibility study with LIBERTY 11/17/20 Microbot Medical receives patents in multiple jursidictions 10/07/20 Microbot Medical receives notice of allowance for U.S. patent 08/17/20 Microbot Medical concludes Liberty Robotic System feasibility animal study MBOT Microbot Medical $8.21 / +0.13 (+1.61%) 08/18/20 H.C. Wainwright Microbot Medical price target raised to $20 from $19 at H.C. Wainwright 05/01/20 H.C. Wainwright Microbot Medical price target lowered to $19 from $26 at H.C. Wainwright MBOT Microbot Medical $8.21 / +0.13 (+1.61%) 11/25/20 Fly Intel: After-Hours Movers
Recommendations	Seagate price target raised to $60 from $41 at Barclays » 07:08 01/21/21 01/21 07:08 01/21/21 07:08 STX Seagate $61.43 / +0.23 (+0.38%) Barclays analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STX Seagate $61.43 / +0.23 (+0.38%) 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products 11/05/20 Climb Channel Solutions adds Seagate data storage systems to distribution line STX Seagate $61.43 / +0.23 (+0.38%) 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital 12/31/20 KeyBanc Industry data points to flat monthly contract pricing for DRAM, says KeyBanc STX Seagate $61.43 / +0.23 (+0.38%) 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c 10/22/20 Notable companies reporting after market close 10/22/20 Fly Intel: What to watch in data storage earnings reports STX Seagate $61.43 / +0.23 (+0.38%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 16:30 Today Seagate - STX STX Seagate $61.43 / +0.23 (+0.38%) 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish 10/22/20 Seagate put volume heavy and directionally bearish

Recommendations	Western Digital price target raised to $46 from $42 at Barclays » 07:07 01/21/21 01/21 07:07 01/21/21 07:07 WDC Western Digital $51.84 / -0.14 (-0.27%) Barclays analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WDC Western Digital $51.84 / -0.14 (-0.27%) 12/16/20 Intel announces next generation of memory and storage products 11/12/20 Twist, Illumina, Western Digital partner with Microsoft over DNA data storage 10/26/20 Dropbox among first to qualify Western Digital's new SMR HDDs 10/16/20 Video game hardware spending rose 15% year-over-year in September, says NPD WDC Western Digital $51.84 / -0.14 (-0.27%) 01/07/21 Stifel Western Digital price target raised to $64 from $54 at Stifel 12/31/20 KeyBanc Industry data points to flat monthly contract pricing for DRAM, says KeyBanc 12/28/20 Mizuho Western Digital price target raised to $59 from $57 at Mizuho 12/18/20 Wells Fargo Western Digital price target raised to $65 from $55 at Wells Fargo WDC Western Digital $51.84 / -0.14 (-0.27%) 10/28/20 Western Digital sees Q2 EPS 40c-60c, consensus 64c 10/28/20 Western Digital reports Q1 EPS 65c, consensus 54c 10/28/20 Notable companies reporting after market close 10/22/20 Fly Intel: What to watch in data storage earnings reports WDC Western Digital $51.84 / -0.14 (-0.27%) 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 10/20/20 Swedish regulators ban Huawei, ZTE from upcoming 5G networks, Reuters reports WDC Western Digital $51.84 / -0.14 (-0.27%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/28/20 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Wall Street's top stories for Monday 09/23/20 Fly Intel: Wall Street's top stories for Wednesday 02/11/21 Technology & Internet Virtual Conference 01/28/21 Western Digital - WDC WDC Western Digital $51.84 / -0.14 (-0.27%) 12/31/20 Early notable gainers among liquid option names on December 31st 12/30/20 Unusually active option classes on open December 30th 12/01/20 Western Digital call volume above normal and directionally bullish 12/01/20 Early notable gainers among liquid option names on December 1st
Hot Stocks	Apellis says 'on track' for Phase 3 GA results in 3Q21 » 07:07 01/21/21 01/21 07:07 01/21/21 07:07 APLS Apellis $49.81 / -2.67 (-5.09%) Apellis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events APLS Apellis $49.81 / -2.67 (-5.09%) 12/10/20 Swedish Orphan Biovitrum, Apellis report results from PEGASUS study 12/10/20 Apellis and Sobi report top-line Phase 3 results of pegcetacoplan in PNH 12/07/20 Apellis announces new analyses from Phase 3 PEGASUS study 11/19/20 Swedish Orphan Biovitrum, Apellis announce first patient dosed in MERIDIAN study APLS Apellis $49.81 / -2.67 (-5.09%) 12/14/20 Roth Capital Apellis price target raised to $73 from $50 at Roth Capital 12/10/20 Cowen Apellis price target raised to $55 from $45 at Cowen 12/04/20 JPMorgan Apellis price target raised to $87 from $50 at JPMorgan 12/01/20 BMO Capital Apellis price target raised to $66 from $57 at BMO Capital APLS Apellis $49.81 / -2.67 (-5.09%) 11/02/20 Apellis reports Q3 EPS ($1.79), consensus ($1.58) 07/31/20 Apellis reports Q2 EPS ($1.57), consensus ($1.39) APLS Apellis $49.81 / -2.67 (-5.09%) 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Fly Intel: Wall Street's top stories at midday 05/14/21 PDUFA Date for Pegcetacoplan
Hot Stocks	Mytheresa to begin trading on NYSE on January 21 » 07:07 01/21/21 01/21 07:07 01/21/21 07:07 MYTE Mytheresa $0.00 / + (+0.00%) MYT Netherlands Parent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 21 Jan MYTE Mytheresa $0.00 / + (+0.00%) 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market
Recommendations	Varonis price target raised to $175 from $150 at Barclays » 07:06 01/21/21 01/21 07:06 01/21/21 07:06 VRNS Varonis $183.01 / +2.75 (+1.53%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VRNS Varonis $183.01 / +2.75 (+1.53%) 01/19/21 Varonis announces new features for Varonis Data Security Platform VRNS Varonis $183.01 / +2.75 (+1.53%) 01/05/21 Piper Sandler Varonis price target raised to $180 from $140 at Piper Sandler 12/18/20 Truist Varonis price target raised to $160 from $145 at Truist 12/17/20 Barclays Varonis downgraded to Equal Weight with $150 target at Barclays 12/17/20 Barclays Varonis downgraded to Equal Weight from Overweight at Barclays VRNS Varonis $183.01 / +2.75 (+1.53%) 10/27/20 Varonis reports Q3 non-GAAP EPS 6c, consensus (13c) 10/26/20 Varonis sees Q4 EPS 10c-13c, consensus (2c) 08/03/20 Varonis sees Q3 EPS (14c)-(11c), consensus (16c) 08/03/20 Varonis reports Q2 EPS (77c), consensus (35c) VRNS Varonis $183.01 / +2.75 (+1.53%) 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 10/26/20 Fly Intel: After-Hours Movers 08/03/20 Fly Intel: After-Hours Movers 02/08/21 Varonis - VRNS
Recommendations	BNY Mellon price target raised to $49 from $43 at RBC Capital » 07:06 01/21/21 01/21 07:06 01/21/21 07:06 BK BNY Mellon $42.51 / -3.3 (-7.20%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BK BNY Mellon $42.51 / -3.3 (-7.20%) 01/19/21 BNY Mellon to implement data management platform for Janus Henderson 01/13/21 BNY Mellon, Amundi announce strategic alliance 12/18/20 BNY Mellon to resume share buyback program in 1Q21 12/16/20 Guardian Capital to acquire BNY Mellon's Canadian wealth management business BK BNY Mellon $42.51 / -3.3 (-7.20%) 06:29 Today Citi BNY Mellon earnings selloff a 'bit overdone,' says Citi 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi 01/11/21 Piper Sandler BNY Mellon price target raised to $47 from $40 at Piper Sandler BK BNY Mellon $42.51 / -3.3 (-7.20%) 01/20/21 BNY Mellon reports Q4 ex-items EPS 96c, consensus 91c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/16/20 BNY Mellon reports Q3 EPS 98c, consensus 94c BK BNY Mellon $42.51 / -3.3 (-7.20%) 10/06/20 BNY Mellon, NCB Capital enter deal for expansion in Saudi Arabia, Bloomberg says 09/21/20 Global banks moved allegedly illegal funds, Reuters reports 09/21/20 JPMorgan, other banks moved large sums of illicit cash, ICIJ reports 08/26/20 BNY Mellon: Majority of employees can work remotely until Jan., Bloomberg says BK BNY Mellon $42.51 / -3.3 (-7.20%) 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 02/24/21 22nd Annual Virtual Financial Services Forum 02/01/21 BNY Mellon

Hot Stocks	INmune Bio says XPro1595 found to decrease nueroinflammation biomarkers » 07:06 01/21/21 01/21 07:06 01/21/21 07:06 INMB INmune Bio $25.09 / -1.61 (-6.03%) INmune Bio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events INMB INmune Bio $25.09 / -1.61 (-6.03%) 01/13/21 INmune Bio to host KOL webinar on Phase 1b trial of XPro1595 11/09/20 INmune Bio doses first patient in Phase 2 trial of Quellor 10/05/20 INmune Bio presents preliminary Phase 1 data in AD patients 09/16/20 INmune Bio awarded $2.9M NIH SBIR grant to support Phase 2 study of XPro1595 INMB INmune Bio $25.09 / -1.61 (-6.03%) 09/01/20 BTIG INmune Bio initiated with a Buy at BTIG 07/14/20 Roth Capital INmune Bio price target raised to $26 from $13 at Roth Capital 03/12/20 H.C. Wainwright INmune Bio price target lowered to $8 from $11 at H.C. Wainwright 03/11/20 Roth Capital INmune makes progress in all programs, novel COVID-19 approach,says Roth Capital INMB INmune Bio $25.09 / -1.61 (-6.03%) 11/05/20 INmune Bio reports Q3 EPS (36c), consensus (17c) 16 Jul 03/15/21 33rd Annual Roth Virtual Conference
Recommendations	PTC price target raised to $142 from $130 at Barclays » 07:05 01/21/21 01/21 07:05 01/21/21 07:05 PTC PTC $130.41 / +4.86 (+3.87%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PTC PTC $130.41 / +4.86 (+3.87%) 12/14/20 PTC to acquire Arena Solutions for $715M in cash 11/10/20 PTC names Troy Richardson as COO 10/28/20 PTC, Rockwell Automation extend strategic alliance 09/08/20 Teradata promotes Hillary Ashton to chief product officer PTC PTC $130.41 / +4.86 (+3.87%) 01/12/21 Mizuho PTC price target raised to $150 from $130 at Mizuho 12/21/20 Deutsche Bank PTC price target raised to $132 from $120 at Deutsche Bank 12/16/20 Needham PTC price target raised to $125 from $100 at Needham 12/16/20 Loop Capital PTC price target raised to $140 from $110 at Loop Capital PTC PTC $130.41 / +4.86 (+3.87%) 12/16/20 PTC Q1 ARR tracking to midpoint of $1.28B-$1.32B guidance range 10/28/20 PTC sees FY21 non-GAAP EPS $2.65-$2.85, consensus $2.83 10/28/20 PTC reports Q4 non-GAAP EPS 78c, consensus 55c 10/28/20 PTC reports Q4 non-GAAP EPS 78c, consensus 55c PTC PTC $130.41 / +4.86 (+3.87%) 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 07/29/20 Fly Intel: After-Hours Movers 01/27/21 PTC - PTC 02/10/21 PTC Inc
Earnings	Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c » 07:05 01/21/21 01/21 07:05 01/21/21 07:05 BKR Baker Hughes $22.91 / +0.03 (+0.13%) Reports Q4 revenue $5.5B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $22.91 / +0.03 (+0.13%) 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $22.91 / +0.03 (+0.13%) 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan 12/15/20 Citi Baker Hughes downgraded to Neutral from Buy at Citi BKR Baker Hughes $22.91 / +0.03 (+0.13%) 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open 07/22/20 Baker Hughes reports Q2 adj. EPS (5c), consensus 0c BKR Baker Hughes $22.91 / +0.03 (+0.13%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $22.91 / +0.03 (+0.13%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 09:00 Today Baker Hughes - BKR
Hot Stocks	Golden Nugget Online launching online casino and sports betting in Michigan » 07:05 01/21/21 01/21 07:05 01/21/21 07:05 GNOG Golden Nugget Online $20.89 / +0.48 (+2.35%) Golden Nugget Online has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Options GNOG Golden Nugget Online $20.89 / +0.48 (+2.35%) 01/13/21 Benchmark Golden Nugget Online initiated with a Buy at Benchmark GNOG Golden Nugget Online $20.89 / +0.48 (+2.35%) 01/19/21 Largest borrow rate increases among liquid names
Hot Stocks	Sutro Biopharma says first patient dosed in dose-expansion study of STRO-002 » 07:05 01/21/21 01/21 07:05 01/21/21 07:05 STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) Sutro Biopharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) 12/07/20 Sutro presents data from ongoing Phase 1 dose-escalation study for STRO-001 12/03/20 Sutro Biopharma jumps 20% to $20.38 after 'encouraging' STRO-002 ph.1 data 12/03/20 Sutro Biopharma's saw 'encouraging' phase 1 data for STRO-002 in ovarian cancer 09/09/20 Sutro Biopharma reports Phase 1 data of STRO-002 in ovarian cancer STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) 12/02/20 Stifel Sutro Biopharma initiated with a Buy at Stifel 11/06/20 Piper Sandler Sutro Biopharma price target raised to $22 from $20 at Piper Sandler 09/18/20 Piper Sandler Piper Sandler lays out next potential takeover targets in oncology 09/02/20 Jefferies Sutro Biopharma initiated with a Buy at Jefferies STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) 11/05/20 Sutro Biopharma reports Q3 EPS 45c, consensus (51c) 08/06/20 Sutro Biopharma reports Q2 EPS (94c), consensus (64c) 09 Dec 12 May STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) 12/07/20 Fly Intel: After-Hours Movers 12/04/20 Fly Intel: Wall Street's top stories for Friday 12/04/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Fly Intel: After-Hours Movers STRO Sutro Biopharma $26.45 / -0.48 (-1.78%) 11/09/20 Eleven new option listings and two option delistings on November 9th

Events

Earnings calls, analyst events, roadshows and more

STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
TFC
Today at 08:00

Truist Financial - TFC Conference Calls
SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls
UNP
Today at 08:45

Union Pacific - UNP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

CM Financial Inc (Notes) [6.125% Notes Due 2023] trading halted, volatility trading pause

TODAY'S FREE FLY STORIES

Get Full Fly Access